Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wasana Siyambalapitiyage"'
Autor:
Jotam G. Pasipanodya, Tawanda Gumbo, Shashikant Srivastava, Devyani Deshpande, Chawanga Modongo, Chandima Wasana Siyambalapitiyage Dona
Publikováno v:
Antimicrobial Agents and Chemotherapy
Aminoglycosides such as amikacin are currently used for the treatment of multidrug-resistant tuberculosis (MDR-TB). However, formal pharmacokinetic/pharmacodynamic (PK/PD) studies to identify amikacin exposures and dosing schedules that optimize Myco
Autor:
Robert W. Parkey, Mai Lin, Orhan K. Öz, Xiankai Sun, Zhisu Liu, Gang Ren, Wasana Siyambalapitiyage, Evan R. Simpson, Jun Liu, Asghar Hajibeigi
Publikováno v:
Journal of Nuclear Medicine. 50:1332-1339
Tumor hypoxia is often associated with resistance to chemotherapy. Multidrug resistance type 1 (MDR1) protein is a member of the adenosine triphosphate binding cassette (ABC) proteins, some of which are involved in the multidrug resistance (MDR) phen
Autor:
Shashikant Srivastava, Richard D. Leff, Chandima Wasana Siyambalapitiyage Dona, Claudia Meek, Jotam G. Pasipanodya, Sandirai Musuka, Tawanda Gumbo
Publikováno v:
Antimicrobial agents and chemotherapy. 57(12)
Phenothiazines are being repurposed for treatment of tuberculosis. We examined time-kill curves of thioridazine and first-line drugs against log-growth-phase and semidormant bacilli under acidic conditions and nonreplicating persistent Mycobacterium
There are currently renewed efforts to develop drugs that could shorten the duration of antituberculosis therapy. This is best achieved by optimizing the sterilizing effect. However, the current pathway for the development of new molecules with the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b4df1f18c3a2fe3b081ccb36fd3703
https://europepmc.org/articles/PMC2715614/
https://europepmc.org/articles/PMC2715614/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.